Sleep Medication Use Linked to Poorer Glycemic Control: Study
A recent prospective cross-sectional study published in the Indian Journal of Sleep Medicine (March 2026) found that overall sleep quality did not significantly affect immediate glucose levels in nondiabetic individuals. However, the use of sleep medications emerged as a significant risk factor associated with impaired glycemic control, highlighting the need for cautious use of such medications and further research into their metabolic effects.
Sleep disorders represent a significant but often overlooked public health crisis, as clinical evidence already links inadequate rest to chronic conditions like obesity and cardiovascular disease. Because there is a notable research gap regarding how these patterns affect healthy individuals in developing regions, Praveen Kumar and a team from the Department of Community Medicine at St. Peter’s Medical College, Hospital and Research Institute conducted the investigation to determine the prevalence of sleep disturbances and their specific impact on random blood sugar (RBS) levels.
Therefore, the prospective cross-sectional study employed a two-stage sampling method—utilizing stratified random sampling with proportional allocation followed by simple random sampling—to recruit 130 "apparently healthy" individuals aged 18 to 65 at a Tamil Nadu tertiary healthcare facility between February and June 2025. The researchers followed World Health Organization (WHO) guidelines to define healthy status and excluded pregnant women, shift workers, and individuals with known neurological or psychiatric disorders to focus on a primary endpoint of how Pittsburgh Sleep Quality Index (PSQI) scores relate to RBS levels, measured using a calibrated portable glucometer while adjusting for variables like body mass index (BMI) and waist-to-hip ratio (WHR).
Key Clinical Findings of the Study Include:
High Prevalence of Poor Sleep: The study identified that 36.9% of the healthy participants were classified as poor sleepers based on a global score exceeding five.
Significantly Shorter Sleep Duration: Poor sleepers reported a median of only six hours of rest compared to eight hours for good sleepers, representing a statistically significant deficit.
Comparable Glycemic Levels: The investigation found no significant difference in median random blood glucose between poor and good sleepers, recorded at 103.5 mg/dL and 108.5 mg/dL respectively.
Medication-Induced Glucose Elevation: A critical finding revealed that each unit increase in the sleep medication component score was associated with a 78.8 mg/dL rise in mean blood sugar levels.
Age as an Independent Predictor: Beyond sleep factors, advancing age was found to independently predict higher blood glucose concentrations within this healthy cohort.
The results suggest that while short-term sleep disturbances in nondiabetic adults might not immediately disrupt glycemic stability due to intact physiological compensatory mechanisms, the high prevalence of poor sleep remains a significant health concern. This pattern indicates that reduced sleep duration could serve as an early marker of suboptimal health in individuals who otherwise appear to be in good physical condition.
Thus, the study concludes clinicians should consider integrating routine sleep quality assessments into standard health evaluations to facilitate the early identification of individuals who may be at risk for future metabolic dysregulation.
Although the study is limited by its cross-sectional design and potential recall bias from self-reported data, future prospective research is warranted to clarify the long-term causal relationship between sleep patterns and metabolic health.
Reference
Kumar P, Sanjana L, Rajan R, et al. Sleep Quality and Its Association with Random Blood Glucose in Apparently Healthy South Indian Adults: A Cross-sectional Study. Indian J Sleep Med 2026;21(1):17–23.
